From Moorfields Eye Hospital, London, United Kingdom.
From Moorfields Eye Hospital, London, United Kingdom.
J Cataract Refract Surg. 2013 Jan;39(1):97-104. doi: 10.1016/j.jcrs.2012.08.056. Epub 2012 Nov 14.
To explore the use of the Pulsar Z1 solid-state 213 nm photorefractive laser platform in topography-guided transepithelial photorefractive keratectomy (PRK) for irregular astigmatism.
Moorfields Eye Hospital, London, United Kingdom.
Prospective clinical case series.
Patients with irregular astigmatism after previous refractive surgery or corneal transplantation were treated with topography-guided transepithelial PRK. Preoperatively and 1-year postoperatively, corrected distance visual acuity (CDVA) and secondary outcome measures (including manifest refraction, contrast sensitivity, haze score, index of surface variation, root-mean-square higher-order aberrations, and subjective visual change) were compared between groups. Adjunctive mitomycin-C was not used.
Seven patients had previous refractive surgery, and 7 had previous corneal transplantation. All but 2 patients with a marked haze response had subjective gains in vision and improved CDVA. Gains in CDVA for patients with irregular astigmatism after previous refractive surgery (median 2 lines gain; range 0 to 2 lines gained) were higher than for patients with irregular astigmatism after keratoplasty (median 0 lines; range 5 lines lost to 4 lines gained). Trends in secondary outcome measures were similar, with greater variation in post-keratoplasty patients. Haze scores were higher in post-keratoplasty patients.
213 nm topography-guided transepithelial PRK was easy to perform and well tolerated by patients with irregular astigmatism. Most patients gained CDVA; however, increased haze responses were observed in post-keratoplasty cases.
探索使用 Pulsar Z1 固态 213nm 光致折变激光平台进行地形引导经上皮光折射性角膜切削术(PRK)治疗不规则散光。
英国伦敦 Moorfields 眼科医院。
前瞻性临床病例系列。
对既往屈光手术或角膜移植后出现不规则散光的患者行地形引导经上皮 PRK 治疗。比较术前和术后 1 年的矫正远视力(CDVA)和次要观察指标(包括显性折射、对比敏感度、混浊评分、表面变异指数、均方根高阶像差和主观视觉变化)。未使用辅助丝裂霉素 C。
7 例患者既往行屈光手术,7 例患者既往行角膜移植。除 2 例有明显混浊反应的患者外,所有患者的视力均有主观提高,且 CDVA 改善。与角膜移植后不规则散光患者相比(中位数提高 2 行;范围 0 至 2 行提高),既往屈光手术后不规则散光患者的 CDVA 提高幅度更高。次要观察指标的趋势相似,但角膜移植后患者的变化更大。角膜移植后患者的混浊评分较高。
213nm 地形引导经上皮 PRK 易于操作,且患者耐受性良好。大多数患者的 CDVA 提高;然而,在角膜移植后病例中观察到混浊反应增加。